China reported the successful test of five different vaccines against coronavirus in 2575 volunteers. If further research is successful, the second phase of clinical trials will complete by July, RIA Novosti reported with reference to Deputy Chairman of the state Committee of public health Zeng Yixing.
“currently, we have one recombinant vaccine based on adenoviral vector and four inactivated vaccines,” he said.
It is clarified that all the vaccines were approved by the state Department of supervision of food and drugs.
In addition, the development recognized as safe. Researchers are already receiving data on successful development of the bodies of subjects. Side effects in volunteers were found.
According to the Johns Hopkins University, during the spread of coronavirus in China were infected more than 84 thousand people, with more than 4.6 thousand cases of infection have ended in death.
Despite the fact that in China, the epidemic COVID-19 appeared before other countries and has now almost subsided, the epicenter of the virus, Hubei province, a few days ago recorded the first in a long time, a new case of infection. The Committee on health of the region said that the infected person is in serious condition.
